These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 20702076

  • 21. Does low-dose seretide reverse chronic obstructive pulmonary disease and are the benefits sustained over time? An open-label Swedish crossover cohort study between 1999 and 2005.
    Rustscheff S, Rydén L.
    J Asthma; 2010 Mar; 47(2):214-6. PubMed ID: 20170332
    [Abstract] [Full Text] [Related]

  • 22. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 23. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
    Eguchi Y, Tateishi Y, Umeda N, Yoshikawa T, Kamoi H, Kanazawa H, Kudoh S, Hirata K, Fujimoto S.
    Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
    [Abstract] [Full Text] [Related]

  • 24. COPD: don't use fluticasone + salmeterol. Patients treated with inhaled fluticasone for chronic obstructive pulmonary disease (COPD) are more prone to pneumonia.
    Prescrire Int; 2007 Dec; 16(92):257-8. PubMed ID: 18092426
    [No Abstract] [Full Text] [Related]

  • 25. Inhaled salmeterol/fluticasone propionate: a review of its use in chronic obstructive pulmonary disease.
    Fenton C, Keating GM.
    Drugs; 2004 Dec; 64(17):1975-96. PubMed ID: 15329047
    [Abstract] [Full Text] [Related]

  • 26. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 27. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
    Kunisaki KM, Rice KL, Janoff EN, Rector TS, Niewoehner DE.
    Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
    [Abstract] [Full Text] [Related]

  • 28. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.
    Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM.
    Am J Respir Crit Care Med; 2008 Aug 15; 178(4):332-8. PubMed ID: 18511702
    [Abstract] [Full Text] [Related]

  • 29. [Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial].
    Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC, Cosmic COPD and Serentide: A Multi-Center Intervention and Characterization Study Group.
    Rev Port Pneumol; 2005 Aug 15; 11(6):587-9. PubMed ID: 16514718
    [No Abstract] [Full Text] [Related]

  • 30. [Salmeterol + fluticasone in COPD. Complementary treatment principles hold true in the COPD management, too].
    MMW Fortschr Med; 2003 Nov 13; 145(46):47. PubMed ID: 14699834
    [No Abstract] [Full Text] [Related]

  • 31. Fluticasone/salmeterol: labeling change.
    Prescrire Int; 2008 Dec 13; 17(98):229. PubMed ID: 19418648
    [Abstract] [Full Text] [Related]

  • 32. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD.
    O'Donnell DE, Sciurba F, Celli B, Mahler DA, Webb KA, Kalberg CJ, Knobil K.
    Chest; 2006 Sep 13; 130(3):647-56. PubMed ID: 16963658
    [Abstract] [Full Text] [Related]

  • 33. Prevention of death in COPD.
    Kupfer Y, Tessler S.
    N Engl J Med; 2007 May 24; 356(21):2212-3; author reply 2213-4. PubMed ID: 17526086
    [No Abstract] [Full Text] [Related]

  • 34. Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.
    Johnson M, Agusti AG, Barnes NC.
    COPD; 2008 Dec 24; 5(6):369-75. PubMed ID: 19353351
    [Abstract] [Full Text] [Related]

  • 35. Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibility.
    Bleecker ER, Emmett A, Crater G, Knobil K, Kalberg C.
    Pulm Pharmacol Ther; 2008 Aug 24; 21(4):682-8. PubMed ID: 18541448
    [Abstract] [Full Text] [Related]

  • 36. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct 24; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

  • 37. Outcomes and costs associated with initial maintenance therapy with fluticasone propionate-salmeterol xinafoate 250 microg/50 microg combination versus tiotropium in commercially insured patients with COPD.
    Dalal AA, Candrilli SD, Davis KL.
    Manag Care; 2011 Aug 24; 20(8):46-50, 53-5. PubMed ID: 21887993
    [Abstract] [Full Text] [Related]

  • 38. Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD.
    Guenette JA, Webb KA, O'Donnell DE.
    Respir Med; 2013 May 24; 107(5):708-16. PubMed ID: 23421968
    [Abstract] [Full Text] [Related]

  • 39. Cost-effectiveness of salmeterol, fluticasone, and combination therapy for COPD.
    Oba Y.
    Am J Manag Care; 2009 Apr 24; 15(4):226-32. PubMed ID: 19355795
    [Abstract] [Full Text] [Related]

  • 40. Controlled trial of inhaled fluticasone propionate in moderate to severe COPD.
    Thompson WH, Carvalho P, Souza JP, Charan NB.
    Lung; 2002 Apr 24; 180(4):191-201. PubMed ID: 12391509
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.